LENALIDOMIDE | A217265 | QILU PHARMACEUTICAL CO LTD
2:2022cv03753
2022-10-14
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
No patent or exclusivity listings for this strength.